News Focus
News Focus
Followers 28
Posts 617
Boards Moderated 0
Alias Born 08/25/2023

Re: glenn1919 post# 220

Friday, 11/08/2024 12:29:05 PM

Friday, November 08, 2024 12:29:05 PM

Post# of 300
NASDAQ: $CRDL
ARCHER trial completed enrollment, with results expected in Q1 2025. Orphan status could lead to $120M peak sales 

Promising early results, potential approval by 2027, targeting $609M peak sales

Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDL News